Tatsugami, K., Oya, M., Kabu, K., & Akaza, H. (2018). Efficacy and safety of sorafenib for advanced renal cell carcinoma: Real-world data of patients with renal impairment. Oncotarget.
Citación estilo ChicagoTatsugami, Katsunori, Mototsugu Oya, Koki Kabu, and Hideyuki Akaza. "Efficacy and Safety of Sorafenib for Advanced Renal Cell Carcinoma: Real-world Data of Patients With Renal Impairment." Oncotarget 2018.
Cita MLATatsugami, Katsunori, Mototsugu Oya, Koki Kabu, and Hideyuki Akaza. "Efficacy and Safety of Sorafenib for Advanced Renal Cell Carcinoma: Real-world Data of Patients With Renal Impairment." Oncotarget 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.